ADSORBED TETANUS VACCINE (VTA) injection suspension medication leaflet

J07AM01 • adsorbed tetanus vaccine • Antiinfectives for systemic use | Bacterial vaccines | Tetanus vaccines

The adsorbed tetanus vaccine is used to prevent tetanus, a serious infection caused by the bacterium Clostridium tetani. This bacterium produces a toxin that affects the nervous system, causing severe muscle spasms and, in severe cases, can be fatal. The vaccine contains tetanus toxoid (an inactivated form of the tetanus toxin) adsorbed onto an adjuvant, such as aluminum hydroxide, to enhance the immune response.

The vaccine is administered via intramuscular injection, usually in the arm (deltoid muscle). It is part of the routine vaccination schedule, given in childhood as part of combination vaccines (e.g., DTP - diphtheria, tetanus, pertussis) and requires periodic booster doses in adults, typically every 10 years.

Side effects are generally mild and include pain, redness, or swelling at the injection site, mild fever, or fatigue. Severe allergic reactions are extremely rare.

The adsorbed tetanus vaccine is essential for preventing tetanus, especially in cases of contaminated wounds or exposure to high-risk environments. It is important for patients to follow the recommended vaccination schedule to maintain long-term protection.